Literature DB >> 10333830

Prevalence of gestational diabetes mellitus among James Bay Cree women in northern Quebec.

S Rodrigues1, E Robinson, K Gray-Donald.   

Abstract

BACKGROUND: The prevalence of gestational diabetes mellitus has been reported to vary widely in aboriginal populations. Most of the data have come from the United States. To help determine the extent of gestational diabetes in Canada's aboriginal population, the authors assessed the prevalence in a population of Cree women in northern Quebec.
METHODS: A cross-sectional study was conducted using the National Diabetes Data Group (NDDG) criteria. Information was obtained from patient charts on pregnancies between January 1995 and December 1996 among women residing in 9 Cree communities in the eastern James Bay region of northern Quebec. Women who were not Cree, had pre-existing diabetes, had spontaneous abortion or were receiving glucocorticoid treatment were excluded.
RESULTS: Data on 654 pregnancies that met the inclusion criteria were available. Results of the screening oral glucose challenge test were available for 579 of the pregnancies; the remaining 75 were excluded. The mean gestational age at screening was 28.3 (standard deviation 2.6) weeks. The prevalence of gestational diabetes was 12.8% (74/579) (95% confidence interval [CI] 10.1%-15.5%). The prevalence in the inland communities was twice as high as that in the coastal communities (18.0% v. 9.3%, p = 0.002). Women with gestational diabetes or impaired glucose tolerance tended to be older, have had more pregnancies, weigh more before pregnancy and have heavier babies than those with a normal glycemic status.
INTERPRETATION: The prevalence of gestational diabetes among James Bay Cree women in northern Quebec is twice as high as that among women in the general North American population and the second highest reported in an aboriginal group worldwide.

Entities:  

Mesh:

Year:  1999        PMID: 10333830      PMCID: PMC1230310     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  22 in total

1.  Summary and recommendations of the Third International Workshop-Conference on Gestational Diabetes Mellitus.

Authors:  B E Metzger
Journal:  Diabetes       Date:  1991-12       Impact factor: 9.461

2.  Geographical distribution of diabetes among the native population of Canada: a national survey.

Authors:  T K Young; E J Szathmary; S Evers; B Wheatley
Journal:  Soc Sci Med       Date:  1990       Impact factor: 4.634

3.  Race/ethnicity and other risk factors for gestational diabetes.

Authors:  G S Berkowitz; R H Lapinski; R Wein; D Lee
Journal:  Am J Epidemiol       Date:  1992-05-01       Impact factor: 4.897

4.  The relationship of one abnormal glucose tolerance test value and pregnancy complications.

Authors:  M K Lindsay; W Graves; L Klein
Journal:  Obstet Gynecol       Date:  1989-01       Impact factor: 7.661

5.  Estimates of gestational age.

Authors:  J D Knoke; R J Sokol
Journal:  JAMA       Date:  1989-04-28       Impact factor: 56.272

6.  Detection and treatment of gestational diabetes.

Authors:  D R Coustan; M W Carpenter
Journal:  Clin Obstet Gynecol       Date:  1985-09       Impact factor: 2.190

7.  Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians.

Authors:  D J Pettitt; W C Knowler; H R Baird; P H Bennett
Journal:  Diabetes Care       Date:  1980 May-Jun       Impact factor: 19.112

8.  Prevalence of gestational diabetes in a Navajo Indian community.

Authors:  J R Sugarman
Journal:  West J Med       Date:  1989-05

9.  Gestational diabetes mellitus. Influence of race on disease prevalence and perinatal outcome in a U.S. population.

Authors:  S L Dooley; B E Metzger; N H Cho
Journal:  Diabetes       Date:  1991-12       Impact factor: 9.461

10.  Abnormal glucose tolerance during pregnancy in Pima Indian women. Long-term effects on offspring.

Authors:  D J Pettitt; P H Bennett; M F Saad; M A Charles; R G Nelson; W C Knowler
Journal:  Diabetes       Date:  1991-12       Impact factor: 9.461

View more
  23 in total

1.  Planning research for greater community involvement and long-term benefit. Special working group of the Cree Regional Child and Family Services Committee.

Authors: 
Journal:  CMAJ       Date:  2000-11-14       Impact factor: 8.262

2.  Intervening to reduce weight gain in pregnancy and gestational diabetes mellitus in Cree communities: an evaluation.

Authors:  K Gray-Donald; E Robinson; A Collier; K David; L Renaud; S Rodrigues
Journal:  CMAJ       Date:  2000-11-14       Impact factor: 8.262

3.  Ironies most bittersweet.

Authors:  P F Hall
Journal:  CMAJ       Date:  1999-05-04       Impact factor: 8.262

Review 4.  The increasing prevalence of diabetes in pregnancy.

Authors:  Kelly J Hunt; Kelly L Schuller
Journal:  Obstet Gynecol Clin North Am       Date:  2007-06       Impact factor: 2.844

5.  Risk reduction for type 2 diabetes in Aboriginal children in Canada.

Authors: 
Journal:  Paediatr Child Health       Date:  2005-01       Impact factor: 2.253

6.  [Not Available].

Authors: 
Journal:  Paediatr Child Health       Date:  2005-01       Impact factor: 2.253

7.  A Guide for Health Professionals Working with Aboriginal Peoples: Health Issues Affecting Aboriginal Peoples.

Authors: 
Journal:  J SOGC       Date:  2001-01

Review 8.  Effect of dietary and lifestyle factors on the risk of gestational diabetes: review of epidemiologic evidence.

Authors:  Cuilin Zhang; Yi Ning
Journal:  Am J Clin Nutr       Date:  2011-05-25       Impact factor: 7.045

9.  Managing diabetes during pregnancy. Guide for family physicians.

Authors:  Ian P Sempowski; R L Houlden
Journal:  Can Fam Physician       Date:  2003-06       Impact factor: 3.275

10.  Smoking during pregnancy and risk of abnormal glucose tolerance: a prospective cohort study.

Authors:  Amy E Haskins; Elizabeth R Bertone-Johnson; Penelope Pekow; Elena Carbone; Renée T Fortner; Lisa Chasan-Taber
Journal:  BMC Pregnancy Childbirth       Date:  2010-09-17       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.